These patients not only expand the mutational and phenotypic spectrum of North Sea PME but also suggest that GOSR2 should be added to the list of monogenic causes of dystonia, epilepsy, and global delay [83,84]. The gene discussed is GOSR2; the disease is progressive myoclonus epilepsy.